Apogee Therapeutics Shows Market Leadership With Jump To 92 RS Rating

By Investor's Business Daily | Jul 9, 2024 at 03:00 AM EST

IBD identifies the Magnificent Seven stocks with a proprietary rating from 1 to 99, indicating price movement compared to other stocks. High RS Rating stocks often lead to significant gains. Apogee Therapeutics is now extended, suggesting a new buying opportunity may arise.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.